Gray Lab
Dr. Gray is overseeing one of the nation’s few facilities that manufactures a special type of gene-delivering virus for patient use.
- Steven Gray, Ph.D.
Dr. Gray is overseeing one of the nation’s few facilities that manufactures a special type of gene-delivering virus for patient use.
The general focus of the Green Lab is to understand the molecular mechanism of the mammalian circadian clock, how it controls rhythmic biochemistry, physiology and behavior and how loss of clock function can impact health, resulting in metabolic disease, cancer and other ailments.
The Greenberg Lab focuses on translational research relative to autoimmune disorders of the central nervous system.
The Greenberg lab is focused on the development of novel therapeutic approaches to combat infectious diseases. For specific projects, please click on the links to the left.
Our lab uses a combination of electrophysiological and molecular techniques to examine functions sub-served by these states at the cellular and circuit levels.
Working at the boundary between science and philosophy with the goal to inform public policy and advance science education and public understanding of science.
We use theoretical methods to study proteins, genomes and organisms.
The Grow lab takes genome-wide, single-cell, and computational approaches to deeply understand epigenome and transcriptome landscapes and how they are reprogrammed.
Our goal is to tackle difficult problems in human health and cancer biology. We work on the diseases of triple-negative breast cancer and other difficult-to-treat cancers.
Dr. Grundy's major research area is in cholesterol and lipoprotein metabolism.
The main focus of our laboratory is characterizing the contribution of non-adipocyte cells within adipose tissueto insulin resistance and systemic inflammation in both rodent and human models.
The Gupta Lab employs modern approaches in molecular genetics and molecular/cellular biology to explore various aspects of adipocyte development.
Our laboratory is interested in improving treatment for patients with glioblastoma (GBM) and other cancers. We work on understanding signal transduction pathways involved in the pathogenesis of cancer. Recent work has focused on investigating mechanisms of resistance to targeted treatment in GBM and lung cancer. We are also interested in mechanisms regulating invasion in GBM.
We employ a variety of methods including evolutionary analysis, genomics, and molecular biology to study the biology of infection.
Our goal is to understand and exploit the immunogenic properties of tumor irradiation in integrating it with immunotherapy to improve cancer patient outcome.
Dr. Harbour’s research focuses on the use of genetic and genomic technology, cell culture experiments and genetically modified experimental models to understand mechanisms of tumor progression in major forms of eye cancer, including uveal melanoma, retinoblastoma, intraocular lymphoma and others.
Our focus is on gaining a greater understanding of how bacteria on the skin surface affect skin health and diseases.
The Hattori lab studies how neural circuits integrate sensorimotor information, memory, and internal state to guide behavior.
The goal of our research lab is to identify the early steps in the pathogenesis of AMD, and to investigate the novel methods to treat and even to prevent its development.
Heart-Brain Connection Program
The Hendrixson Lab is largely focused on exploring the biology of polarly-flagellated bacterial pathogens….and junk food, donuts, and cake.
The primary goal of Henkemeyer laboratory is to understand the biochemical signals that regulate cell-cell interactions during embryonic development.
Henne lab is interested in how cells spatially organize their metabolism to adapt to a constantly changing environment.
The Henning lab develops novel ultra-high field MRI and metabolic MRI methodology for human application and translates it to neuroscientific, physiological and clinical trials in brain, spine, heart and muscle disorders.
The goal of the Herz Lab is to identify the underlying biochemical principles of human diseases & disorders in order to design novel therapies to prevent, delay, or cure them.